Drug Pricing
Commentary
Government Health Insurance: An Offer Businesses Should Refuse
Executives at many large corporations want the government to take on a greater role providing health coverage and controlling costs, according to a new Kaiser Family Foundation survey. That seems to indicate big business is sympathetic to the core of the Democrats’ healthcare agenda, including the idea of a public option ...
Commentary
Democratic drug pricing bill is a house of cards
House Democrats just introduced H.R. 3, a bill that would allow the government to cap drug prices based on what they cost in six other developed nations. President Joe Biden is sympathetic to the idea. In his speech to Congress this week, he called for giving the federal government the power to negotiate drug ...
Commentary
With HR 3, House Democrats Lose Their Grip on Reality
Last week, House Democrats introduced H.R. 3, a bill that would empower the federal government to set prescription drug prices for the entire U.S. pharmaceutical market. The measure comes at the worst possible time. The rapid development of effective vaccines against COVID-19 has demonstrated what can happen when the drug industry ...
Commentary
Europe Negotiates A Poor Vaccine Rollout
Several European countries just instituted another round of lockdowns amid a new wave of Covid-19 cases. This turn of events is sobering but puzzling. Europe seemed to have Covid-19 under control a few months ago, at least compared to the United States. What happened? The countries’ vaccination rates offer an explanation. Europe ...
Blog
Here They Go Again: The Democratic Obsession with Drug Price Controls Will Harm Patients and Diminish Innovation
The U.S. House of Representatives is once again considering “The Lower Drug Costs Now Act”. It was a bad idea in the last Congress, and it is still bad policy today. If it becomes law, this Act (H.R. 3) empowers the federal government to negotiate prices on select drugs for ...
Commentary
Drug Importation Programs Come At Too High a Cost
Lawmakers in Colorado are trying to open their state’s borders to prescription drugs from abroad. In 2019, they green-lit imports from Canada. They’re still working on a plan to implement that policy that can garner federal approval. Then last week, legislators approved a bill that would allow Coloradans to import prescription drugs ...
Drug Pricing
Sanders Proposal Brings Medicare Closer To The Brink Of Collapse
President Joe Biden wants to lower Medicare’s eligibility age from 65 to 60. Now Sen. Bernie Sanders is intent on doing him one better. The Vermont socialist, the country’s leading promoter of single-payer health care, is pushing Democrats to open up Medicare to Americans as young as 55. “There are many millions of seniors ...
Commentary
Sanders Proposal Brings Medicare Closer To The Brink Of Collapse
President Joe Biden wants to lower Medicare’s eligibility age from 65 to 60. Now Sen. Bernie Sanders is intent on doing him one better. The Vermont socialist, the country’s leading promoter of single-payer health care, is pushing Democrats to open up Medicare to Americans as young as 55. “There are many millions of seniors ...
Drug Pricing
Wayne Winegarden – A Flawed Analysis on Valuing Medicines
The Institute for Clinical and Economic Review (ICER) promotes itself as “the nation’s drug pricing watchdog.” However, as documented in the first of a series of PRI reports, ICER’s cost-effectiveness analyses contain inappropriate methodologies and subjective judgments in determining the value of medicines. In this podcast, PRI senior fellow Wayne ...
Drug Pricing
ISSUE BRIEF: ICER Analyses Are Flawed, Undervalue Life-Saving Medicines, and Are Biased Toward Price Controls
A commonly-used analysis to determine a medicine’s value is based on flawed methodologies that would diminish innovation and access, finds a new report released today by the nonpartisan Center for Medical Economics and Innovation at the Pacific Research Institute. “Cost effectiveness reports may provide precise estimates, but there is no ...
Government Health Insurance: An Offer Businesses Should Refuse
Executives at many large corporations want the government to take on a greater role providing health coverage and controlling costs, according to a new Kaiser Family Foundation survey. That seems to indicate big business is sympathetic to the core of the Democrats’ healthcare agenda, including the idea of a public option ...
Democratic drug pricing bill is a house of cards
House Democrats just introduced H.R. 3, a bill that would allow the government to cap drug prices based on what they cost in six other developed nations. President Joe Biden is sympathetic to the idea. In his speech to Congress this week, he called for giving the federal government the power to negotiate drug ...
With HR 3, House Democrats Lose Their Grip on Reality
Last week, House Democrats introduced H.R. 3, a bill that would empower the federal government to set prescription drug prices for the entire U.S. pharmaceutical market. The measure comes at the worst possible time. The rapid development of effective vaccines against COVID-19 has demonstrated what can happen when the drug industry ...
Europe Negotiates A Poor Vaccine Rollout
Several European countries just instituted another round of lockdowns amid a new wave of Covid-19 cases. This turn of events is sobering but puzzling. Europe seemed to have Covid-19 under control a few months ago, at least compared to the United States. What happened? The countries’ vaccination rates offer an explanation. Europe ...
Here They Go Again: The Democratic Obsession with Drug Price Controls Will Harm Patients and Diminish Innovation
The U.S. House of Representatives is once again considering “The Lower Drug Costs Now Act”. It was a bad idea in the last Congress, and it is still bad policy today. If it becomes law, this Act (H.R. 3) empowers the federal government to negotiate prices on select drugs for ...
Drug Importation Programs Come At Too High a Cost
Lawmakers in Colorado are trying to open their state’s borders to prescription drugs from abroad. In 2019, they green-lit imports from Canada. They’re still working on a plan to implement that policy that can garner federal approval. Then last week, legislators approved a bill that would allow Coloradans to import prescription drugs ...
Sanders Proposal Brings Medicare Closer To The Brink Of Collapse
President Joe Biden wants to lower Medicare’s eligibility age from 65 to 60. Now Sen. Bernie Sanders is intent on doing him one better. The Vermont socialist, the country’s leading promoter of single-payer health care, is pushing Democrats to open up Medicare to Americans as young as 55. “There are many millions of seniors ...
Sanders Proposal Brings Medicare Closer To The Brink Of Collapse
President Joe Biden wants to lower Medicare’s eligibility age from 65 to 60. Now Sen. Bernie Sanders is intent on doing him one better. The Vermont socialist, the country’s leading promoter of single-payer health care, is pushing Democrats to open up Medicare to Americans as young as 55. “There are many millions of seniors ...
Wayne Winegarden – A Flawed Analysis on Valuing Medicines
The Institute for Clinical and Economic Review (ICER) promotes itself as “the nation’s drug pricing watchdog.” However, as documented in the first of a series of PRI reports, ICER’s cost-effectiveness analyses contain inappropriate methodologies and subjective judgments in determining the value of medicines. In this podcast, PRI senior fellow Wayne ...
ISSUE BRIEF: ICER Analyses Are Flawed, Undervalue Life-Saving Medicines, and Are Biased Toward Price Controls
A commonly-used analysis to determine a medicine’s value is based on flawed methodologies that would diminish innovation and access, finds a new report released today by the nonpartisan Center for Medical Economics and Innovation at the Pacific Research Institute. “Cost effectiveness reports may provide precise estimates, but there is no ...
